E-QURE Corp. engages in providing medical devices. Its product includes the Bioelectrical Signal Therapy, which is used to treat chronic wounds which include Diabetic Foot Ulcers, Pressure (Decubitus) Ulcers, and Vascular (Arterial and Venous) Leg Ulcers. The company was founded on August 31, 1988 and is headquartered in New York, NY.
Company profile
Ticker
EQUR
Exchange
Website
CEO
Ohad Goren
Employees
Location
Fiscal year end
Industry (SIC)
Former names
ADB International Group, Inc.
SEC CIK
EQUR stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
6 Oct 23
NT 10-Q
Notice of late quarterly filing
17 May 22
NT 10-K
Notice of late annual filing
28 Mar 22
10-Q
2021 Q3
Quarterly report
13 Jan 22
NT 10-Q
Notice of late quarterly filing
10 Nov 21
10-Q
2021 Q2
Quarterly report
29 Sep 21
NT 10-Q
Notice of late quarterly filing
13 Aug 21
10-Q
2021 Q1
Quarterly report
6 Jul 21
NT 10-Q
Notice of late quarterly filing
14 May 21
10-K
2020 FY
Annual report
30 Apr 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 11.50 k | 11.50 k | 11.50 k | 11.50 k | 11.50 k | 11.50 k |
Cash burn (monthly) | 792.33 | 16.07 k | 50.58 k | 66.47 k | 14.61 k | 43.18 k |
Cash used (since last report) | 23.76 k | 481.99 k | 1.52 mm | 1.99 mm | 438.18 k | 1.30 mm |
Cash remaining | -12.26 k | -470.49 k | -1.51 mm | -1.98 mm | -426.68 k | -1.28 mm |
Runway (months of cash) | -15.5 | -29.3 | -29.8 | -29.8 | -29.2 | -29.7 |